Comments
Drug firm Suven Life Sciences today reported 7.8 per cent increase in standalone net profit at ₹40.06 crore for the fourth quarter ended March 2017.
The company had posted a net profit of ₹37.16 crore during the same period of last fiscal, Suven Life Sciences said in a BSE filing.
Net sales of the company rose 3.3 per cent to ₹174.99 crore during the quarter under review as against ₹169.37 crore in the year—ago period.
For the entire fiscal, the company reported a consolidated net profit of ₹87.18 crore. It had posted a net profit of ₹ 71.84 crore in the 2015—16 fiscal.
Its net sales for the fiscal stood at ₹ 539.16 crore as compared to ₹ 500.28 crore in the year—ago period.
The company said its board has declared and paid an interim dividend of Re 1 per share for FY17.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.